Table: Pharmarise Holdings - 6-MTH group results

Pharmarise Holdings

29/12/2022 08:00

Dec 29 (Reuters)- 
             Pharmarise Holdings Corp 
             CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)                
                   6 months ended      6 months ended       Year to 
                  Nov 30, 2022        Nov 30, 2021     May 31, 2023 
                     LATEST             YEAR-AGO          LATEST    
                     RESULTS             RESULTS         FORECAST   
  Sales               25.75               25.90            51.79    
                   (-0.6 pct)          (+0.9 pct)       (+0.4 pct)  
  Operating          573 mln             788 mln            1.41    
                   (-27.3 pct)         (+50.1 pct)      (-7.2 pct)  
  Recurring          566 mln             814 mln            1.38    
                   (-30.4 pct)         (+51.8 pct)      (-9.1 pct)  
  Net                72 mln              250 mln          397 mln   
                   (-71.0 pct)         (+96.5 pct)      (-11.3 pct) 
  EPS               7.76 yen            26.94 yen        42.27 yen  
  EPS Diluted       5.93 yen            20.34 yen                   
  Ann Div                               14.00 yen        14.00 yen  
  -Q2 div              NIL                 NIL                      
  -Q4 div                               14.00 yen        14.00 yen  
  
  NOTE - Pharmarise Holdings Corp. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=2796.T